PORTLAND, Oregon, April 12, 2016 /PRNewswire/ --
According to a new report published by Allied Market Research titled, "World Biosurgery Market - Opportunities and Forecasts, 2014-2022," the world biosurgery market is expected to reach $12,758.1 million by 2022 with a CAGR of 8.1% from 2015 to 2022. Hemostatic and surgical sealing agents segment collectively held about half of the market share in 2015, which is expected to flourish over the forecast period. The neuro and spine surgery application segment is likely to lead the biosurgery market throughout the study period.
To know more about the report, visit the website at https://www.alliedmarketresearch.com/biosurgery-market
The world biosurgery market is projected to grow at a substantial rate owing to rise in sport and spine-related injuries, per capita healthcare expenditure, rise in number of surgeries due to increase in obese population along with lifestyle disorders and others. Also, availability of multi-functional products would provide a lucrative market opportunity; for instance, apart from fibrin's use as surgical sealants, it is also used as hemostatic agents to prevent excessive blood loss during cardiothoracic and orthopedic surgeries. However, factors that would hamper the market growth are high cost associated with surgeries, stern regulatory environment for product approval, and growing popularity of minimally invasive surgeries.
The bone graft substitutes segment contributed to one-third share in the overall biosurgery market in 2015. This segment covers products such as cell-based matrices, bone morphogenetic proteins, demineralized bone matrix, and synthetic graft extenders. However, surgical sealant agents segment is expected to grow at the highest growth rate during the forecast period because of the availability of multifunctional products. The neuro- and spine surgery application segment is projected to dominate the market due to high penetration of bone graft substitute products usage in the surgeries. Also, currently biologics products are more popular compared to synthetic biosurgical products, and this trend is expected to continue during the analysis period.
Key findings of the study:
Surgical sealants is projected to be the fastest growing segment in the world biosurgery market with a CAGR of 10.7% from 2015 to 2022.
Hemostatic agents segment is expected to overtake the bone graft substitute segment, and reach $4.3 billion by 2022.
Neuro- and spine surgery application segment is projected to dominate this market throughout the forecast period.
Biologic biosurgical products segment would continue to lead the world biosurgery market with about three fourth of the market share in 2015.
Asia-Pacific is projected to be the fastest growing biosurgery market with a CAGR of 10.7% from 2015 to 2022.
The North American biosurgery market offers lucrative growth opportunities owing to its developed economy, high public awareness, rising patient pool, and arrival of new multifunctional products. Developing countries such as India, China, Brazil, and South Korea are expected to boost the market growth with rapid change in healthcare infrastructure and increase in purchasing power. Increase in medical tourism, heavy investment by top players in R&D activities, and low cost surgeries are projected to boost the market growth during the analysis period, particularly in the Asia-Pacific region.
The key companies profiled in this report are Medtronic PLC, Baxter International Inc., C. R. Bard Inc., Johnson and Johnson, Stryker Corporation, Sanofi S.A., Atrium Medical Corporation (Maquet Getinge Group), Hemostasis LLC, CryoLife Inc., and Kuros Bioscience.
Similar Studies published by Allied Market Research -
World Surgical Equipment Market - The global surgical equipment market is expected to grow at significant CAGR of 11.1% during the forecast period. Inception of modern electronic technologies such as minimally invasive surgery equipment, and robotic and power assisted systems are primarily driving the surgical equipment market.
To know more about the surgical equipment market report, visit the website at https://www.alliedmarketresearch.com/surgical-equipment-market
World Surgical Robotics Market - The world surgical robotic systems market was evaluated at $3.3 billion in 2014, and is estimated to garner $6.4 billion by 2020, registering a CAGR of 10.2% over the forecast period. The increasing need for automation in the healthcare sector and growing demand for minimally invasive surgeries are the major factors driving the surgical robotic systems and procedures market.
To know more about the surgical robotics Market report, visit the website at https://www.alliedmarketresearch.com/surgical-robotics-market
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285 (U.S. & Canada)
SOURCE Allied Market Research